Entera Bio

$1.84
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.07 (-3.98%) Today

+$0.15 (+8.88%) As of 10:14 AM UTC after-hours

Why Robinhood?

You can buy or sell Entera Bio and other stocks, options, and ETFs commission-free!

About ENTX

Entera Bio Ltd. Ordinary Shares, also called Entera Bio, is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of orally delivered large molecule therapeutics. It develops an oral formulation of parathyroid hormone. The company was founded on June 1, 2010 and is headquartered in Jerusalem, Israel. The listed name for ENTX is Entera Bio Ltd. Ordinary Shares.

CEO

Spiros Jamas

Employees

Headquarters

Jerusalem, Jerusalem

Founded

2009

Market Cap

34.18M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

704.80K

High Today

$1.76

Low Today

$1.66

Open Price

$1.76

Volume

300.68K

52 Week High

$3.40

52 Week Low

$1.00

Collections

ENTX Earnings

-$0.26

-$0.17

-$0.09

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 25, Pre-Market